Clinical Trial Update: A Vehicle Controlled Study to Evaluate Safety and Efficacy of Topical TMB-001 for Treatment of Congenital Ichthyosis [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating safety and efficacy of topical TMB-001 for congenital ichthyosis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Ichthyosis

Drugs mentioned

• TMB-001

Snippet

Sponsor: Timber Pharmaceuticals Inc. | Conditions: Congenital Ichthyosis | Phase 2 | Status: COMPLETED | Results posted: 2022-08-25